Relay Therapeutics (RLAY) Earnings Date, Estimates & Call Transcripts $2.69 +0.08 (+3.07%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.68 -0.02 (-0.56%) As of 04/17/2025 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Relay Therapeutics Earnings Summary Upcoming Earnings DateMay. 1After Market ClosesEstimatedConsensus EPS (Feb. 26) -$0.57 Actual EPS (Feb. 26) -$0.45 Beat By $0.12 Relay Therapeutics issued Q4 2024 earnings on February 26, 2025, reporting an EPS of -$0.45, which topped the consensus estimate of -$0.57 by $0.12. With a trailing EPS of -$2.39, Relay Therapeutics' earnings are expected to decrease next year, from ($2.55) to ($2.73) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)RLAY Upcoming EarningsRelay Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Relay Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Relay Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRLAY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RLAY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Relay Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.63-$0.56-$0.60Q2 20252-$0.58-$0.51-$0.55Q3 20252-$0.72-$0.60-$0.66Q4 20252-$0.74-$0.61-$0.68FY 20258($2.67)($2.28)($2.48) Relay Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)--------2/26/2025Q4 2024-$0.57-$0.45+$0.12-$0.45$5.53M-11/6/2024Q3 2024-$0.77-$0.63+$0.14-$0.63$0.09M-8/6/2024Q2 2024-$0.73-$0.69+$0.04-$0.69$0.09M-5/2/2024Q1 2024-$0.70-$0.62+$0.08-$0.62$0.12M$10.01M2/22/2024Q4 2023-$0.76-$0.67+$0.09-$0.67$0.64M-11/2/2023Q3 2023-$0.83-$0.54+$0.29-$0.54$0.78M$25.20M8/8/2023Q2 2023-$0.78-$0.81 -$0.03-$0.81$0.81M$0.12M5/4/2023Q1 2023-$0.70-$0.78 -$0.08-$0.78$0.16M$0.23M Relay Therapeutics Earnings - Frequently Asked Questions When is Relay Therapeutics's earnings date? Relay Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on RLAY's earnings history. Did Relay Therapeutics beat their earnings estimates last quarter? In the previous quarter, Relay Therapeutics (NASDAQ:RLAY) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.57) by $0.12. Learn more on analysts' earnings estimate vs. RLAY's actual earnings. How much revenue does Relay Therapeutics generate each year? Relay Therapeutics (NASDAQ:RLAY) has a recorded annual revenue of $10.01 million. How much profit does Relay Therapeutics generate each year? Relay Therapeutics (NASDAQ:RLAY) has a recorded net income of -$341.97 million. RLAY has generated -$2.39 earnings per share over the last four quarters. What is Relay Therapeutics's EPS forecast for next year? Relay Therapeutics's earnings are expected to decrease from ($2.55) per share to ($2.73) per share in the next year. More Earnings Resources from MarketBeat Related Companies JANX Earnings Results BEAM Earnings Results ARWR Earnings Results HRMY Earnings Results KYMR Earnings Results GLPG Earnings Results BHC Earnings Results CNTA Earnings Results AGIO Earnings Results ARQT Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth Ahead This page (NASDAQ:RLAY) was last updated on 4/18/2025 by MarketBeat.com Staff From Our Partners🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RLAY Stock Free RLAY Stock Alerts